Virginia Tech spinout Landos Biopharma priced its shares at $16 to raise $100m and will use proceeds to advance the development of two treatments for inflammatory bowel disease.

The healthcare RPA technology developer has revealed $21.4m in funding from investors including Gradient Ventures, where founding CEO Ankit Jain used to work.

Johnson & Johnson-backed cancer biospy developer Inivata has added $35m to a series C round anchored by $25m from NeoGenomics in May.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

V-Bio Ventures, the venture firm affiliated with VIB, will focus on healthcare and sustainable agriculture companies primarily in Belgium.

Hewlett Packard Enterprise and Novartis dRx Capital helped the data management technology developer secure funding that will support product development.

Cambridge and CRUK spinout Inivata has more than doubled its series C round to $60m following a $35m extension backed by IP Group.

Gree and Shanghai Kindly-backed, respiratory-focused medical device and drug developer Resproly has closed a round led by CAS Investment Management.

The Engine has co-led by $16m seed round for Cellino, which is working on a process to automate the generation of stem cells at scale.

CAS Investment Management, a subsidiary of Chinese Academy of Sciences, has backed medical devices developer Resproly’s series B round.